Caxton Associates (New York)’s Cartesian Therapeutics RNAC Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-814	Closed	-$33.9K	–	623
2023 Q1	$33.9K	Sell	814 -2,426	-75%	-$101K	0.01%	473
2022 Q4	$110K	Hold	3,240	–	–	0.01%	398
2022 Q3	$159K	Buy	+3,240	New	+$159K	0.02%	412